PR Newswire
Lunai Bioworks, Inc. Issues Letter to Shareholders
📈
AI Sentiment
Highly Positive
10/10
- Home
- LNAI
LNAI
Lunai Bioworks Inc.
as of 02-11-2026 4:00pm EST
$0.81
$0.25
-23.59%
Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.
Upcoming Earnings Alert:
Get ready for potential market movements as Lunai Bioworks Inc. (LNAI) prepares to release earnings report on 13 Feb 2026.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | SUITE 906 LOS ANGELES |
| Market Cap: | 18.3M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 256.6K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -7.22 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.63 - $14.00 | Next Earning Date: | 02-13-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | -7207429.0 | FCF Growth: | N/A |
Latest Lunai Bioworks Inc. News
LNAI Breaking Stock News: Dive into LNAI Ticker-Specific Updates for Smart Investing
PR Newswire
Lunai Bioworks (NASDAQ: LNAI) Launches AI Oncology Pilot with Clinical-Stage Partner to Analyze Randomized Phase 2 Metastatic Colorectal Cancer Survival Trial Data
📈
AI Sentiment
Highly Positive
8/10
Compare LNAI vs Leading Stocks
See how LNAI stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "LNAI Lunai Bioworks Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.